News Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Email Alerts

Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go

Advanced Search

Keywords

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Nov 11, 2015

  Insmed to Present at the Stifel 2015 Healthcare Conference
• Nov 6, 2015

  Insmed Reports Third Quarter 2015 Financial Results and Provides Business Update
• Oct 31, 2015

  Insmed to Host Third Quarter 2014 Financial Results Conference Call on Thursday, November 6, 2014
• Oct 29, 2015

  Insmed to Host Third Quarter 2015 Financial Results Conference Call on Friday, November 6, 2015
• Oct 26, 2015

  Insmed Announces Upcoming Data Presentation at AMCP Nexus 2015
• Oct 19, 2015

  The Balancing Act(R) on Lifetime to Feature NTM Lung Disease
• Oct 14, 2015

  INSMED Launches Comprehensive Educational Campaign to Raise Awareness of NTM Lung Disease

  NTMfacts.com Provides a Dynamic Resource for Healthcare Providers to Learn More About NTM Lung Disease Through Patient Testimonials and Case Studies
• Oct 6, 2015

  Insmed Announces Upcoming Data Presentations at Infectious Disease Week 2015
• Sep 22, 2015

  Insmed Announces Upcoming Data Presentations at ERS 2015
• Sep 14, 2015

  Insmed Announces Upcoming Data Presentations at ICAAC/ICC 2015
• Sep 5, 2015

  Insmed to Present at the Rodman & Renshaw Annual Global Investment Conference
• Sep 3, 2015

  Insmed to Present at the Leerink Partners Rare Disease Roundtable
• Aug 11, 2015

  Insmed Announces Proposed Public Offering of Common Stock
• Aug 6, 2015

  Insmed Reports Second Quarter 2015 Financial Results and Provides Business Update
• Jul 28, 2015

  Insmed to Host Second Quarter 2015 Financial Results Conference Call on Thursday, August 6, 2015
• Jun 17, 2015

  Insmed to Participate at the JMP Securities Life Sciences Conference
• May 13, 2015

  Insmed Announces Upcoming Data Presentations at the American Thoracic Society 2015 International Meeting
• May 11, 2015

  Insmed to Participate at the UBS Global Healthcare Conference
• May 7, 2015

  Insmed Reports First Quarter 2015 Financial Results
• Apr 6, 2015

  Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
• Mar 31, 2015

  Insmed Announces Pricing of Public Offering of Common Stock
• Mar 30, 2015

  Insmed Announces Proposed Public Offering of Common Stock
• Mar 27, 2015

  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• Mar 23, 2015

  Insmed Appoints Dr. Eugene Sullivan as Chief Medical and Scientific Officer

  20 Year Industry Veteran Brings Industry, Clinical and Regulatory Experience in Pulmonary and Orphan Diseases
• Feb 27, 2015

  Insmed Reports 2014 Fourth Quarter and Full Year Financial Results

  Marketing Authorization Application for ARIKAYCETM Validated by the European Medicines Agency
• Feb 24, 2015

  Insmed to Participate at Cowen & Company's 35th Annual Health Care Conference
• Jan 28, 2015

  Insmed to Participate at February Investment Conferences
• Jan 13, 2015

  Insmed Incorporated Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• Jan 6, 2015

  Insmed to Present at the 33rd Annual J.P. Morgan Healthcare Conference
• Dec 15, 2014

  Insmed Provides End of Year Regulatory and Clinical Update
• Dec 15, 2014

  Insmed Appoints Myrtle Potter to its Board of Directors

  Pharmaceutical executive brings 30 years of commercial and operations leadership
• Nov 26, 2014

  Insmed to Participate at December Investment Conferences
• Nov 6, 2014

  Insmed Reports Third Quarter 2014 Financial Results

  Conference Call Begins Today at 8:30 a.m. Eastern Time
• Sep 24, 2014

  Insmed to Participate in Leerink Partners' Rare Disease Roundtable
• Sep 3, 2014

  Insmed Announces Multiple Clinical and Scientific Presentations at European Respiratory Society's International Congress 2014
• Aug 18, 2014

  Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
• Aug 12, 2014

  Insmed Announces Pricing of Public Offering of Common Stock
• Aug 6, 2014

  Insmed Reports Second Quarter 2014 Financial Results
• Aug 4, 2014

  Insmed Provides Regulatory Update for ARIKAYCE

  Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications
• Jun 20, 2014

  Insmed to Present at the JMP Securities Healthcare Conference
• May 29, 2014

  Insmed Appoints David R. Brennan to Its Board of Directors
• May 20, 2014

  Insmed Announces Positive Open Label Data from Phase 2 Clinical Trial of ARIKAYCE for Treatment Resistant Nontuberculous Mycobacterial Lung Infections

  Poster Presentation at the American Thoracic Society Annual Meeting 2014
• May 13, 2014

  Insmed Announces Data Presentations for ARIKAYCE in Two Orphan Lung Diseases at the American Thoracic Society Meeting
• May 12, 2014

  Insmed to Participate in the Bank of America Merrill Lynch 2014 Health Care Conference
• May 8, 2014

  Insmed Reports First Quarter 2014 Financial Results
• Apr 7, 2014

  Insmed to Participate in the 13th Annual Needham & Co. Healthcare Conference
• Apr 2, 2014

  Insmed Announces Leadership Team Transitions and Appointments to Expand Support for Growth Opportunities
• Mar 26, 2014

  Insmed Announces Results from Phase 2 Clinical Trial for Treatment Resistant Nontuberculous Mycobacterial Lung Infections

  Conference Call with Insmed Management and Clinical Trial Investigators Will be Held Today at 8:00 a.m. Eastern Time
• Mar 25, 2014

  Insmed to Announce Results From U.S. Phase 2 Clinical Trial for Treatment Resistant Nontuberculous Mycobacteria Lung Infections
• Mar 6, 2014

  Insmed Reports 2013 Fourth Quarter and Full Year Financial Results

Show 5102550100 per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download